Dividen
Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
Imbal Hasil Dividen
—
Rasio Pembayaran Dividen
—
CAGR Dividen 5T
—
Tanggal ex-dividen
Jumlah
13 Jan. 2023
$24,0000
21 Sep. 2022
$143,0000
CBIO Konsensus Analis
Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI15 analis
Beli Kuat
640,0%
Beli
746,7%
Tahan
213,3%
Jual
00,0%
Jual Kuat
00,0%
Target Harga 12 Bulan
5 analis
· 2026-08-19
Median$28.00
Rata-rata$30.60
← Di bawah semua target
$17.39
Rendah$27.00
Tinggi$35.00
Target median$28.00
+61,0%
Target rata-rata$30.60
+75,9%
Riwayat Pendapatan
EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.18%
Periode
EPS Aktual
EPS Estimasi
Kejutan
30 Juni 2026
$-0.74
$-0.81
0.07%
31 Maret 2026
$-0.70
$-0.97
0.27%
31 Des. 2025
$-0.54
$-2.57
2.0%
30 Sep. 2025
$-1.27
$-2.02
0.75%
30 Juni 2025
$-4.93
$-1.80
-3.1%
31 Maret 2025
$-4.00
$-5.10
1.1%
Perbandingan rekan (sub-industri GICS)
Metrik utama vs rekan sektor
Ticker
Kapitalisasi Pasar
P/E
Pendapatan YoY
Margin Bersih
ROE
Margin Kotor
CBIO
$327M
-24.2
-86.7%
-1419.6%
-90.0%
—
ALLO
$314M
-1.6
-76.8%
—
-59.9%
—
GYRE
$645M
353.0
10.2%
8.5%
11.7%
—
TECX
$391M
-5.2
—
—
-27.7%
—
SGMT
—
-3.7
—
—
-42.3%
—
NVCT
$194M
-5.7
—
—
-149.9%
—
ASMB
$539M
-61.8
153.5%
-8.5%
-5.5%
—
MDXG
$1.00B
21.2
20.0%
11.6%
20.5%
82.6%
SPRY
$1.16B
-6.7
-5.5%
-203.3%
-111.8%
—
ALT
$400M
-3.6
105.0%
-214861.0%
-45.6%
—
Fundamental Lengkap
Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi14
Data Laporan Laba Rugi Tahunan untuk CBIO
Metrik
Tren
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue
$11M
·
$10.0K
$75.0K
$1M
$10M
·
·
·
$18.5K
$20M
$15M
R&D Expense
$138M
$14M
$20M
$28M
$47M
$45M
$47M
$40M
$24M
$23M
$25M
$20M
SG&A Expense
$25M
$18M
$19M
$19M
$17M
$17M
$14M
$11M
$10M
$9M
$8M
$7M
Operating Expenses
$163M
$40M
$39M
$47M
$65M
$62M
$61M
$52M
$34M
$32M
$33M
$26M
Operating Income
$-153M
$-40M
$-39M
$-47M
$-63M
$-52M
$-61M
$-52M
$-34M
$-32M
$-13M
$-11M
Other Non-op
·
$2M
$2M
·
·
·
·
·
$651.2K
$103.6K
$15.3K
$18.2K
Pretax Income
$-152M
·
·
·
·
·
·
·
·
·
·
·
Income Tax
$2M
·
·
·
·
·
·
·
·
·
·
·
Net Income
$-154M
$-38M
$-37M
$-47M
$-63M
$-51M
$-58M
$-48M
$-33M
$-32M
$-13M
$-11M
EPS (Basic)
·
$-0.59
$-0.58
$-0.89
$-1.23
$-1.12
$-1.34
·
·
·
·
$-0.60
EPS (Diluted)
·
$-0.59
$-0.58
$-0.89
$-1.23
$-1.12
$-1.34
·
·
·
·
$-0.60
Shares (Basic)
·
64,477,249
63,342,465
52,531,173
51,453,204
45,721,139
43,254,782
·
·
·
·
18,452,252
Shares (Diluted)
·
64,477,249
63,342,465
52,531,173
51,453,204
45,721,139
43,254,782
·
·
·
·
18,452,252
EBITDA
$-153M
$-40M
$-39M
$-47M
$-63M
$-52M
$-61M
$-52M
$-34M
$-32M
$-13M
$-11M
Neraca21
Data Neraca Tahunan untuk CBIO
Metrik
Tren
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Cash & Equivalents
$213M
$35M
$42M
$48M
$90M
$137M
$158M
$210M
$124M
$40M
$47M
$55M
Receivables
$18M
$0
·
·
·
·
·
·
·
·
·
·
Prepaid Expense
$5M
$38.0K
$2M
$3M
$533.8K
$1M
$4M
$2M
$3M
$478.5K
$441.8K
$916.2K
Other Current Assets
$5M
$38.0K
·
·
·
·
·
·
·
·
·
·
Current Assets
$237M
$35M
$44M
$51M
$91M
$138M
$163M
$212M
$127M
$41M
$47M
$56M
PP&E (Net)
$846.0K
$0
·
$242.4K
$368.8K
$620.7K
$822.9K
$957.2K
$1M
$1M
$521.4K
$452.3K
PP&E (Gross)
·
·
·
$3M
$3M
$3M
$3M
$3M
$2M
$2M
$1M
$1M
Accum. Depreciation
·
·
·
$2M
$2M
$2M
$2M
$2M
$1M
$1M
$902.1K
$905.5K
Other Non-current Assets
$1M
$813.0K
·
·
·
·
·
·
·
·
·
·
Total Assets
$240M
$36M
$45M
$52M
$94M
$143M
$168M
$215M
$129M
$42M
$48M
$57M
Accounts Payable
·
$329.3K
$868.1K
$970.2K
$2M
$2M
$1M
$3M
$3M
$2M
$564.2K
$874.0K
Accrued Liabilities
$16M
$2M
$5M
$7M
$9M
$9M
$9M
$6M
$4M
$3M
$6M
$5M
Current Liabilities
$36M
$10M
$7M
$9M
$12M
$12M
$11M
$9M
$8M
$6M
$8M
$6M
Capital Leases
$1M
$0
$66.8K
·
$918.6K
$2M
$3M
·
·
·
·
·
Total Liabilities
$37M
$47M
$7M
$9M
$13M
$15M
$14M
$9M
$9M
$7M
$8M
$6M
Common Stock
$28.0K
$1.0K
$64.4K
$54.4K
$52.3K
$49.0K
$43.5K
$43.2K
$34.4K
$23.2K
$19.0K
$18.9K
Paid-in Capital
$371M
$2M
$495M
$462M
$454M
$438M
$413M
$406M
$272M
$154M
$128M
$125M
Retained Earnings
$-172M
$-18M
$-456M
$-420M
$-373M
$-309M
$-258M
$-201M
$-152M
$-119M
$-87M
$-74M
Stockholders' Equity
$203M
$-15M
$38M
$43M
$82M
$128M
$154M
$205M
$120M
$35M
$40M
$51M
Liabilities + Equity
$240M
$36M
$45M
$52M
$94M
$143M
$168M
$215M
$129M
$42M
$48M
$57M
Shares Outstanding
27,556,767
1,018,604
64,393,744
54,377,798
52,313,894
49,017,622
43,466,933
43,160,751
34,359,799
23,250,023
19,050,204
18,939,838
Arus Kas11
Data Arus Kas Tahunan untuk CBIO
Metrik
Tren
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Stock-based Comp
$13M
$5M
$4M
$4M
$6M
$7M
$6M
$5M
$4M
$3M
$2M
$2M
Deferred Tax
$0
·
·
·
·
·
·
·
·
·
·
·
Restructuring
·
$7M
·
·
·
·
·
·
·
·
·
·
Operating Cash Flow
$-72M
$-31M
$-35M
$-46M
$-57M
$-39M
$-52M
$-43M
$-30M
$-30M
$-8M
$-4M
CapEx
$919.0K
$10.0K
$21.4K
$84.2K
$14.9K
$68.5K
$144.9K
$125.6K
$294.1K
$704.2K
$268.6K
$212.6K
Investing Cash Flow
$-73M
$20.0K
$-21.4K
$-84.2K
$-14.9K
$-68.5K
$-144.9K
$-125.6K
$-294.1K
$-704.2K
$-268.6K
·
Stock Issued
$0
·
$29M
$4M
$11M
$18M
·
$128M
$114M
$24M
·
$57M
Net Stock Activity
$0
·
$29M
$4M
$11M
$18M
·
$128M
$114M
$24M
·
$57M
Financing Cash Flow
$323M
$5.4K
$29M
$4M
$11M
$18M
$412.9K
$129M
$114M
$24M
$114.1K
·
Net Change in Cash
$179M
$-31M
$-6M
$-42M
$-47M
$-21M
$-52M
$86M
$84M
$-7M
$-8M
$53M
Free Cash Flow
$-72M
$-31M
$-35M
$-47M
$-58M
$-39M
$-52M
$-43M
$-30M
$-30M
$-9M
$-4M
Profitabilitas7
Data Profitabilitas Tahunan untuk CBIO
Metrik
Tren
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Operating Margin
-1407.5%
·
-392752.9%
-63204.4%
-5470.7%
-506.8%
·
·
·
-172505.3%
-63.7%
-74.1%
Net Margin
-1419.6%
·
-368994.2%
-62251.7%
-5469.0%
-502.1%
·
·
·
-171945.1%
-63.6%
-74.0%
Pretax Margin
-1401.2%
·
·
·
·
·
·
·
·
·
·
·
EBITDA Margin
-1407.5%
·
-392752.9%
-63204.4%
-5470.7%
-506.8%
·
·
·
-172505.3%
-63.7%
-74.1%
ROA
-111.6%
-134.3%
-76.0%
-63.9%
-53.5%
-32.8%
-30.2%
-28.1%
-38.9%
-70.0%
-24.2%
-35.6%
ROE
-90.0%
-1888.5%
-86.9%
-102.6%
-71.2%
-38.3%
-36.0%
-22.8%
-42.9%
-84.0%
-28.0%
-41.4%
ROIC
-76.2%
·
·
·
·
·
·
·
·
·
·
·
Likuiditas & Solvabilitas2
Data Likuiditas & Solvabilitas Tahunan untuk CBIO
Metrik
Tren
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Current Ratio
6.6
1.9
6.4
5.7
7.7
11.1
14.8
24.2
15.6
6.4
6.1
8.7
Quick Ratio
6.4
1.9
6.1
5.4
7.6
11.0
14.4
24.0
15.2
6.3
6.0
8.5
Efisiensi2
Data Efisiensi Tahunan untuk CBIO
Metrik
Tren
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Asset Turnover
0.1
·
0.0
0.0
0.0
0.1
·
·
·
0.0
0.4
0.5
Receivables Turnover
1.2
·
·
·
·
·
·
·
·
·
·
·
Per Saham5
Data Per Saham Tahunan untuk CBIO
Metrik
Tren
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Book Value / Share
$7.37
$0.08
$0.60
$0.79
$1.56
$2.62
$3.55
$4.76
$3.48
$1.52
$2.12
$2.68
Revenue / Share
·
·
$0.00
$0.00
$0.02
·
·
·
·
·
·
$0.81
Cash Flow / Share
·
$-0.48
$-0.55
$-0.88
$-1.12
·
·
·
·
·
·
$-0.23
Cash / Share
$7.74
$0.17
$0.65
$0.88
$1.73
$2.80
$3.64
$4.86
$3.61
$1.72
$2.46
$2.91
EPS (TTM)
$-0.49
$-0.59
$-0.58
$-0.89
$-1.23
$-1.12
$-1.34
$-0.75
$-0.75
$-0.75
$-0.71
$-0.60
Tingkat Pertumbuhan3
Data Tingkat Pertumbuhan Tahunan untuk CBIO
Metrik
Tren
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue YoY
·
·
-86.7%
-93.5%
-88.6%
·
·
·
·
·
·
·
Revenue CAGR 3Y
424.9%
·
-90.0%
·
·
·
·
·
·
·
·
·
Revenue CAGR 5Y
1.3%
·
·
·
·
·
·
·
·
·
·
·
Valuasi (TTM)10
Data Valuasi (TTM) Tahunan untuk CBIO
Metrik
Tren
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue TTM
$11M
·
$10.0K
$75.0K
$1M
$10M
·
·
·
$18.5K
$20M
$15M
Net Income TTM
$-154M
$-38M
$-37M
$-47M
$-63M
$-51M
$-58M
$-48M
$-33M
$-32M
$-13M
$-11M
Market Cap
$327M
$1.61B
$15.20B
$16.48B
$7.53B
$18.43B
$22.99B
$40.87B
$57.69B
$14.18B
$10.90B
$13.64B
P/E
-24.2
-42.4
-406.9
-340.4
-117.1
-335.7
-394.8
-1262.7
-2238.7
-813.3
-805.6
-1200.0
P/S
30.1
·
1519692.4
219686.3
6495.4
1813.5
·
·
·
766622.4
542.9
907.5
P/B
1.6
303.4
395.6
383.8
92.3
143.7
149.1
198.9
481.9
401.8
269.2
268.4
P / Tangible Book
1.6
·
395.6
383.8
92.3
143.7
·
·
·
·
·
·
P / Cash Flow
-4.6
-51.8
-435.7
-354.7
-131.0
-469.7
-442.3
-943.3
-1938.0
-477.0
-1322.1
-3185.0
P / FCF
-4.5
-51.8
-435.4
-354.0
-131.0
-468.8
-441.1
-940.5
-1919.0
-466.0
-1280.4
-3034.3
Earnings Yield
-4.1%
-2.4%
-0.25%
-0.29%
-0.85%
-0.30%
-0.25%
-0.08%
-0.04%
-0.12%
-0.12%
-0.08%
Laporan Laba Rugi13
Data Triwulanan Laporan Laba Rugi untuk CBIO
Metrik
Tren
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Revenue
$0
$1M
·
·
$0
$0
·
·
·
·
·
·
·
·
$0
·
R&D Expense
$19M
$18M
$106M
$20M
$12M
$11M
$233.2K
$2M
$6M
$6M
$5M
$5M
$4M
$5M
$6M
$5M
SG&A Expense
$9M
$8M
$9M
$6M
$9M
$4M
$5M
$4M
$4M
$5M
$4M
$5M
$5M
$6M
$5M
$4M
Operating Expenses
$28M
$26M
$114M
$26M
$21M
$14M
$7M
$11M
$10M
$11M
$10M
$10M
$9M
$11M
$11M
$9M
Operating Income
$-26M
$-25M
$-103M
$-26M
$-21M
$-14M
$-7M
$-11M
$-10M
$-11M
$-10M
$-10M
$-9M
$-11M
$-11M
$-9M
Other Non-op
$2M
$1M
·
$1M
$-760.0K
$-924.0K
$110.1K
$1M
·
·
$512.2K
$611.0K
·
·
·
·
Income Tax
$0
$0
$2M
$0
$0
$0
·
·
·
·
·
·
·
·
·
·
Net Income
$-25M
$-23M
$-23M
$-25M
$-22M
$-15M
$-7M
$-10M
$-10M
$-11M
$-9M
$-9M
$-8M
$-10M
$-10M
$-9M
EPS (Basic)
·
·
·
·
·
$-0.04
$-0.11
$-0.15
$-0.16
$-0.17
$-0.14
$-0.14
$-0.13
$-0.17
$-0.20
$-0.16
EPS (Diluted)
·
·
·
·
·
·
$-0.24
$-0.15
$-0.16
$-0.04
$-0.14
$-0.14
$-0.13
$-0.17
$-0.20
$-0.16
Shares (Basic)
·
·
·
·
·
64,522,257
-128,947,790
64,483,958
64,483,848
64,457,233
-125,633,555
64,349,709
64,276,184
60,350,127
-104,631,509
52,423,944
Shares (Diluted)
·
·
·
·
·
·
-129,012,814
64,483,958
64,483,848
64,522,257
-129,740,661
64,349,709
64,276,184
64,457,233
-104,631,509
52,423,944
EBITDA
$-26M
·
·
$-26M
$-21M
$-2M
·
$-11M
$-10M
$-11M
·
$-10M
$-9M
$-11M
·
$-9M
Neraca21
Data Triwulanan Neraca untuk CBIO
Metrik
Tren
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Cash & Equivalents
$172M
$189M
$213M
$133M
$153M
$6M
$11M
$14M
$22M
$31M
$42M
$49M
$58M
$65M
$48M
$52M
Receivables
$0
$0
$18M
·
·
·
·
·
·
·
·
·
·
·
·
·
Prepaid Expense
$7M
$6M
$5M
$1M
$2M
$378.0K
$371.3K
$1M
$1M
$2M
$2M
$3M
$2M
$3M
$3M
$2M
Other Current Assets
$7M
$6M
$5M
·
·
·
·
·
·
·
·
·
·
·
·
·
Current Assets
$179M
$196M
$237M
$135M
$154M
$6M
$11M
$16M
$24M
$33M
$44M
$52M
$60M
$68M
$51M
$54M
PP&E (Net)
$876.0K
$929.0K
$846.0K
$782.0K
$193.0K
·
·
·
·
·
·
$133.0K
$167.9K
$200.7K
·
$288.1K
PP&E (Gross)
·
·
·
·
·
·
·
·
·
·
·
$3M
$3M
$3M
·
$3M
Accum. Depreciation
·
·
·
·
·
·
·
·
·
·
·
$3M
$2M
$2M
·
$2M
Other Non-current Assets
$1M
$1M
$1M
$1M
$1M
·
·
·
·
·
·
·
·
·
·
·
Total Assets
$183M
$199M
$240M
$138M
$157M
$6M
$11M
$16M
$24M
$34M
$45M
$53M
$62M
$69M
$52M
$56M
Accounts Payable
·
·
·
·
·
$104.7K
$329.3K
$581.8K
$950.8K
$755.5K
$868.1K
$329.9K
$241.5K
$480.2K
$970.2K
$852.1K
Accrued Liabilities
$7M
$4M
$16M
$9M
$8M
$3M
$5M
$3M
$3M
$4M
$5M
$5M
$6M
$6M
$7M
$6M
Current Liabilities
$19M
$14M
$36M
$20M
$17M
$3M
$6M
$4M
$4M
$5M
$7M
$6M
$7M
$7M
$9M
$8M
Capital Leases
$966.0K
$1M
$1M
$1M
$1M
·
·
·
·
·
$66.8K
$262.1K
$448.8K
·
·
$95.6K
Total Liabilities
$20M
$15M
$37M
$22M
$18M
$3M
$6M
$4M
$4M
$5M
$7M
$7M
$7M
$7M
$9M
$8M
Common Stock
$28.0K
$28.0K
$28.0K
$14.0K
$14.0K
$64.5K
$64.5K
$64.5K
$64.5K
$64.5K
$64.4K
$64.4K
$64.3K
$64.2K
$54.4K
$52.4K
Paid-in Capital
$379M
$375M
$371M
$192M
$190M
$500M
$500M
$498M
$497M
$496M
$495M
$494M
$493M
$492M
$462M
$457M
Retained Earnings
$-220M
$-195M
$-172M
$-79M
$-55M
$-497M
$-494M
$-487M
$-477M
$-467M
$-456M
$-447M
$-438M
$-430M
$-420M
$-409M
Stockholders' Equity
$163M
$184M
$203M
$117M
$139M
$3M
$5M
$11M
$20M
$29M
$38M
$47M
$55M
$62M
$43M
$48M
Liabilities + Equity
$183M
$199M
$240M
$138M
$157M
$6M
$11M
$16M
$24M
$34M
$45M
$53M
$62M
$69M
$52M
$56M
Shares Outstanding
27,756,044
27,571,935
27,556,767
13,892,516
13,892,562
64,532,091
64,483,958
64,483,958
64,483,958
64,450,835
64,393,744
64,368,843
64,313,333
64,245,224
54,377,798
52,423,944
Arus Kas10
Data Triwulanan Arus Kas untuk CBIO
Metrik
Tren
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Stock-based Comp
$4M
$4M
$5M
$2M
$6M
$1M
$1M
$1M
$1M
$1M
$908.4K
$887.8K
$858.1K
$870.2K
$899.2K
$914.0K
Restructuring
·
·
·
·
·
·
·
$5M
·
·
·
·
·
·
·
·
Operating Cash Flow
$-19M
$-9M
$-27M
$-18M
$-22M
$-11M
$-4M
$-8M
$-9M
$-11M
$-8M
$-9M
$-7M
$-12M
$-8M
$-9M
CapEx
$13.0K
$147.0K
$193.0K
$586.0K
$140.0K
$0
$0
$0
$2.5K
$7.4K
$801
$7.9K
$10.5K
$2.2K
$1
$2.5K
Investing Cash Flow
$2M
$-8M
$-72M
$-586.0K
$-140.0K
$0
$30.0K
$0
$-2.5K
$-7.4K
$-801
$-7.9K
$-10.5K
$-2.2K
$-1
$-2.5K
Stock Issued
·
·
·
·
·
·
·
·
·
·
$0
$0
$0
$29M
·
·
Net Stock Activity
·
·
·
·
·
·
·
·
·
·
·
·
·
$29M
·
·
Financing Cash Flow
$136.0K
$-7M
$179M
$-1M
$147M
$-1M
$0
$0
$500
$4.9K
$999
$61.6K
$20.1K
$29M
·
·
Net Change in Cash
$-18M
$-24M
$80M
$-19M
$123M
$-12M
$-4M
$-8M
$-9M
$-11M
$-8M
$-9M
$-7M
$17M
$-4M
$-9M
Free Cash Flow
·
·
·
·
·
·
·
·
·
$-11M
·
·
·
$-12M
·
·
Profitabilitas2
Data Triwulanan Profitabilitas untuk CBIO
Metrik
Tren
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
ROA
-14.6%
·
·
-32.0%
-24.0%
-11.7%
·
-28.5%
-23.4%
-20.8%
·
-16.9%
-13.0%
-13.8%
·
-10.4%
ROE
-16.4%
·
·
-38.4%
-27.4%
-14.5%
·
-33.9%
-27.0%
-23.6%
·
-19.4%
-14.9%
-15.9%
·
-11.8%
Likuiditas & Solvabilitas2
Data Triwulanan Likuiditas & Solvabilitas untuk CBIO
Metrik
Tren
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Current Ratio
9.7
·
·
6.6
9.2
2.3
·
3.6
5.5
6.3
·
8.1
9.2
10.1
·
6.9
Quick Ratio
9.3
·
·
6.6
9.1
2.1
·
3.3
5.1
5.9
·
7.7
8.8
9.6
·
6.7
Efisiensi2
Data Triwulanan Efisiensi untuk CBIO
Metrik
Tren
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Asset Turnover
0.0
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Receivables Turnover
0.0
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Per Saham4
Data Triwulanan Per Saham untuk CBIO
Metrik
Tren
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Book Value / Share
$5.88
·
·
$8.40
$10.02
$0.05
·
$0.18
$0.31
$0.45
·
$0.72
$0.85
$0.97
·
$0.92
Cash Flow / Share
·
·
·
·
·
·
·
·
·
$-0.16
·
·
·
$-0.19
·
·
Cash / Share
$6.18
·
·
$9.59
$10.99
$0.09
·
$0.22
$0.35
$0.49
·
$0.77
$0.90
$1.01
·
$0.98
EPS (TTM)
$-0.49
$-0.49
·
$-0.49
$-0.49
$-0.49
·
$-0.49
$-0.47
$-0.48
·
$-0.60
$-0.71
$-0.86
·
$-1.03
Valuasi (TTM)8
Data Triwulanan Valuasi (TTM) untuk CBIO
Metrik
Tren
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Net Income TTM
$-96M
$-93M
·
$-71M
$-57M
$-46M
·
$-40M
$-38M
$-39M
·
$-36M
$-40M
$-47M
·
$-54M
Market Cap
$500M
·
·
$165M
$224M
$1.36B
·
$1.10B
$1.81B
$19.34B
·
$9.66B
$11.19B
$8.09B
·
$2.88B
P/E
-36.7
-37.5
·
-24.3
-32.9
-42.9
·
-34.7
-59.6
-625.0
·
-250.0
-245.1
-146.5
·
-53.4
P/B
3.1
·
·
1.4
1.6
401.5
·
96.4
90.0
668.8
·
207.4
204.2
130.2
·
59.9
P / Tangible Book
3.1
2.8
·
1.4
1.6
401.5
·
96.4
90.0
668.8
·
207.4
204.2
130.2
·
59.9
P / Cash Flow
·
·
·
·
·
-265.4
·
·
·
-1839.9
·
·
·
-697.4
·
·
P / FCF
·
·
·
·
·
·
·
·
·
-1838.6
·
·
·
-697.3
·
·
Earnings Yield
-2.7%
-2.7%
·
-4.1%
-3.0%
-2.3%
·
-2.9%
-1.7%
-0.16%
·
-0.40%
-0.41%
-0.68%
·
-1.9%
Laporan Keuangan
Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Pendapatan
$11M
—
$10.0K
$75.0K
$1M
Margin Operasi %
-1407.5%
—
-392752.9%
-63204.4%
-5470.7%
Laba Bersih
$-154M
$-38M
$-37M
$-47M
$-63M
EPS Dilusian
—
$-0.59
$-0.58
$-0.89
$-1.23
Neraca
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Rasio Lancar
6.6
1.9
6.4
5.7
7.7
Rasio Cepat
6.4
1.9
6.1
5.4
7.6
Arus Kas
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Arus Kas Bebas
$-72M
$-31M
$-35M
$-47M
$-58M
Metrik Saya
Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F)
82 pengaju · $470.5M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru
Posisi yang keluar
Meningkat
Menurun
Perubahan bersih saham
35
(+21 vs Kuartal sebelumnya)
12
(+2 vs Kuartal sebelumnya)
14
(-3 vs Kuartal sebelumnya)
15
(+7 vs Kuartal sebelumnya)
+3.5M
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+
4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF
Dimiliki oleh 10 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.